Antimicrobial resistance in developing countries. Part II: strategies for containment (Q36240854)

13 August 2017

1 reference

title

Antimicrobial resistance in developing countries. Part II: strategies for containment (English)

1 reference

13 August 2017

1

Iruka N Okeke

0 references

Zulfiqar Bhutta

series ordinal

3

object named as

Zulfiqar A Bhutta

1 reference

13 August 2017

2

Keith P Klugman

1 reference

13 August 2017

8

Ramanan Laxminarayan

1 reference

13 August 2017

4

Adriano G Duse

1 reference

13 August 2017

7

Ariel Pablos-Mendez

1 reference

13 August 2017

Philip Jenkins

5

1 reference

PubMed ID

16122680

13 August 2017

Thomas F O'Brien

series ordinal

6

1 reference

13 August 2017

1 September 2005

1 reference

Lancet Infectious Diseases

13 August 2017

1 reference

13 August 2017

5

1 reference

13 August 2017

9

1 reference

13 August 2017

568-580

1 reference

Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype typhimurium infections

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Antimicrobial resistance in developing countries. Part I: recent trends and current status

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Improving antibiotic use in low-income countries: an overview of evidence on determinants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Improving parent knowledge about antibiotics: a video intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: A controlled intervention trial in rural Alaska

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Clonal spread of resistant pneumococci despite diminished antimicrobial use.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Antibiotic resistance: consequences of inaction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Risk factors for fecal quinolone-resistant Escherichia coli in Mexican children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Evaluating treatment protocols to prevent antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

On the implications of endogenous resistance to medications.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Drug treatment costs: projected impact of using the integrated management of childhood illnesses.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Improving drug use through continuing education: a randomized controlled trial in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Small group intervention vs formal seminar for improving appropriate drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Strategies to improve adherence to recommended chloroquine treatment regimes: a quasi-experiment in the context of integrated primary health care delivery in Ghana.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Malaria chemoprophylaxis compliance in pregnant women: a cost-effectiveness analysis of alternative interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Factors influencing physicians' prescribing behaviour in the treatment of childhood diarrhoea: knowledge may not be the clue.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Infection control strategies in a neonatal intensive care unit in Argentina

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Serotype distribution and antimicrobial resistance patterns in Streptococcus pneumoniae isolates from hospitalized pediatric patients with respiratory infections in Shanghai, China

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Effect of washing hands with soap on diarrhoea risk in the community: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Cost of nosocomial infection in Turkey: an estimate based on the university hospital data.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Sustained improvements in hygiene behaviour amongst village women in Lombok, Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Improving the appropriateness of vancomycin use by sequential interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

An interrupted time series analysis of parenteral antibiotic use in Colombia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Treating dysentery with metronidazole in Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Interactional group discussion: results of a controlled trial using a behavioral intervention to reduce the use of injections in public health facilities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Improving physician prescribing patterns to treat rhinopharyngitis. Intervention strategies in two health systems of Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Impact of an educational program on antibiotic use in a tertiary care hospital in a developing country

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Improving private pharmacy practice: a multi-intervention experiment in Hanoi, Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Randomized, controlled trial of prescribing training in a South African province

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Improving private practitioner care of sick children: testing new approaches in rural Bihar

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Effect of training on the clinical management of malaria by medical assistants in Ghana

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Intervention research in rational use of drugs: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Comparison of knowledge on diarrheal disease management between two types of community-based distributors in Oyo State, Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

STD trends and patterns of treatment for STD by physicians in private practice in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Purchase of antibiotics without prescription in Manila, the Philippines. Inappropriate choices and doses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Reported and actual prescription of oral rehydration therapy for childhood diarrhoeas by retail pharmacists in Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

The use of antimicrobial drugs in Nagpur, India. A window on medical care in a developing country

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Private pharmacies in Hanoi, Vietnam: a randomized trial of a 2-year multi-component intervention on knowledge and stated practice regarding ARI, STD and antibiotic/steroid requests

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

The cost-effectiveness of syndromic management in pharmacies in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Antimicrobial control programs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Evaluation of antibiotic use in a hospital with an antibiotic restriction policy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Management of childhood illness in Africa. Early evaluations show promising results

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

The effect of Integrated Management of Childhood Illness on observed quality of care of under-fives in rural Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Ten recommendations to improve use of medicines in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Have guidelines had an impact on antimicrobial resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Implementation of clinical practice guidelines for upper respiratory infection in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Experimental evaluation of the effects of drug information on antibiotic prescribing: a study in outpatient care in an area of Sri Lanka

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Essential drug list in a rural hospital. Does it have any influence on drug prescription?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

The value and effects of implementing an essential drugs list in the Lagos University Teaching Hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Patients' interviews and misuse of antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Obtaining antibiotics without a prescription

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Parental use and misuse of antibiotics: are there differences in urban vs. suburban settings?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Antibiotic noncompliance and waste in upper respiratory infections and acute diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

A controlled comparison of directly observed therapy vs self-administered therapy for active tuberculosis in the urban United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Coping with Africa's increasing tuberculosis burden: are community supervisors an essential component of the DOT strategy? Directly observed therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Are health personnel the best choice for directly observed treatment in southern Thailand? A comparison of treatment outcomes among different types of observers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Tuberculosis: trends and the twenty-first century

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Does DOTS work in populations with drug-resistant tuberculosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

The failure of pharmaceuticals and the power of plants: medicinal discourse as a critique of modernity in the Amazon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Shortage of penicillin G: impact on antibiotic prescribing at a US tertiary care centre

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

PUBLIC HEALTH: Responding to Market Failures in Tuberculosis Control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Treatment of childhood fevers and other illnesses in three rural Nigerian communities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Interactions between patent medicine vendors and customers in urban and rural Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Drug prescribing practices of general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Antibiotic misuse in diarrhea. A household survey in a Mexican community.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Physician control of pediatric antimicrobial use in Beijing, China, and its rural environs.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

"Doi moi" and private pharmacies: a case study on dispensing and financial issues in Hanoi, Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Sulfadoxine-pyrimethamine in treatment of malaria in Western Kenya: increasing resistance and underdosing

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Extent of antibiotic use in Taiwan shown by antimicrobial activity in urine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Inappropriate use of antibiotics and the risk for delayed admission and masked diagnosis of infectious diseases: a lesson from Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

The general public's perceptions and use of antimicrobials in Trinidad and Tobago

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Export of antimicrobial drugs by West African travelers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Family self-medication and antibiotics abuse for children and juveniles in a Chinese city.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

A research agenda for health education among underserved populations.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Assessing the impact of a regulatory intervention in Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

How best to utilize limited resources

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Quality and bioavailability of tetracycline capsules in a Nigerian semi-urban community

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Assessment of the incidence of substandard drugs in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Pharmacopoeial quality of drugs supplied by Nigerian pharmacies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Pattern of antibiotic use in two teaching hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Antimicrobial-resistant bacterial diarrhea in rural western Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Reality of developing a community-wide antibiogram

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Surveillance of antimicrobial resistance--an international perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Cycling antibiotics may not be good for your health

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Humans as the world's greatest evolutionary force

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Trimethoprim and sulfonamide resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

Building communication networks: international network for the study and prevention of emerging antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970217-6

7 January 2021

10.1016/S1473-3099(05)70217-6

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16122680